Attention-deficit/hyperactivity disorder (ADHD) is a common and impairing disorder affecting
children, adolescents, and adults. Several treatment strategies are available that can …

Economic evaluations can help decision makers identify what services for children with
neurodevelopmental disorders provide best value-for-money. The aim of this paper is to …

Background Childhood illness can impose significant costs and health strains on family
members, but these are not routinely captured by pediatric economic evaluations. This …

Objectives: This systematic review provides an overview of full economic evaluations of
attention-deficit/hyperactivity disorder (ADHD) treatments, evaluates their outcomes, and …

Background Psychosocial (eg, anxiety or behavior) problems lead to costs not only in the
healthcare sector but also in education and other sectors. As psychosocial problems …

The provision of effective care models for children with neurodevelopmental delay or
disability can be challenging in resource constrained healthcare systems. Economic …

Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder in
which a significant proportion of patients do not respond to treatment. The objective of this …

This study was designed to develop a drug-in-adhesive (DIA) type transdermal drug delivery
system (TDDS) for D-threo-methylphenidate (D-threo-MP) that could be further developed …

Objectives. This study aimed to assess the cost-effectiveness of treatments for attention-
deficit/hyperactivity disorder (ADHD) in children through prevention of serious delinquent …

Purpose This prospective, single-arm, open-label, 8-week, multicenter study investigated the
effectiveness of switching from immediate-release methylphenidate (IR-MPH) to osmotic …